Measurement of Current Substance Use in a Cohort of HIV-Infected Persons in Continuity HIV Care, 2007–2015

No abstract is available for this paper.

• Publication year

  2018

• Venue

  American Journal of Epidemiology

• Publication date

  2018-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/aje/kwy092PMID 29701832PMCID PMC6118067
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stan: A Probabilistic Programming Language.

  2017cited by this paper
• Assessing Problematic Substance Use in HIV Care: Which Questions Elicit Accurate Patient Disclosures?

  2016cited by this paper
• Comparison of AUDIT-C collected via electronic medical record and self-administered research survey in HIV infected and uninfected patients.

  2016cited by this paper
• All your data are always missing: incorporating bias due to measurement error into the potential outcomes framework.

  2015cited by this paper
• Cigarette Smoking Prevalence Among Adults With HIV Compared With the General Adult Population in the United States

  2015cited by this paper
• Hui and Walter’s latent-class model extended to estimate diagnostic test properties from surveillance data: a latent model for latent data

  2015cited by this paper
• Estimating Diagnostic Test Accuracies for Brachyspira hyodysenteriae Accounting for the Complexities of Population Structure in Food Animals

  2014cited by this paper
• Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study.

  2013cited by this paper
• A General Latent Class Model for Performance Evaluation of Diagnostic Tests in the Absence of a Gold Standard: An Application to Chagas Disease

  2012cited by this paper
• Berkson's bias, selection bias, and missing data.

  2012cited by this paper
• Smoking and HIV: Prevalence, Health Risks, and Cessation Strategies

  2012cited by this paper
• Patient reported outcomes in routine care: advancing data capture for HIV cohort research.

  2012cited by this paper
• Substance Use and the Quality of Patient-Provider Communication in HIV Clinics

  2011cited by this paper
• Crack-Cocaine Use Accelerates HIV Disease Progression in a Cohort of HIV-Positive Drug Users

  2009cited by this paper
• Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women

  2008cited by this paper
• Substance abuse treatment in human immunodeficiency virus: the role of patient-provider discussions.

  2008cited by this paper
• Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems.

  2008cited by this paper
• Bayesian latent class models with conditionally dependent diagnostic tests: A case study

  2008cited by this paper
• Routine collection of patient-reported outcomes in an HIV clinic setting: the first 100 patients.

  2007cited by this paper
• Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.

  2006cited by this paper
• Prevalence of DSM-IV-Defined Mood, Anxiety, and Substance Use Disorders in an HIV Clinic in the Southeastern United States

  2006cited by this paper
• Sexual risk, substance use, and psychological distress in HIV-positive gay and bisexual men who also inject drugs

  2005cited by this paper
• Modeling sources of self-report bias in a survey of drug use epidemiology.

  2005cited by this paper
• Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse

  2004cited by this paper
• Medically eligible women who do not use HAART: the importance of abuse, drug use, and race.

  2004cited by this paper
• A Structural Approach to Selection Bias

  2004cited by this paper
• Differences in HIV Disease Progression by Injecting Drug Use in HIV-Infected Persons in Care

  2004cited by this paper
• Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems.

  2004cited by this paper
• Bayesian measures of model complexity and fit

  2002cited by this paper
• Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

  2002cited by this paper
• Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

  2002cited by this paper
• Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

  2002cited by this paper
• The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study.

  2002cited by this paper
• Bayesian Approaches to Modeling the Conditional Dependence Between Multiple Diagnostic Tests

  2001cited by this paper
• Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy

  2001cited by this paper
• Screening without a "gold standard": the Hui-Walter paradigm revisited.

  2001cited by this paper
• Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown.

  2000cited by this paper
• The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

  1998cited by this paper
• Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.

  1998cited by this paper
• The AUDIT Alcohol consumption questions (AUDIT-C) : An effective brief screening test for problem drinking

  1998cited by this paper
• Validity of self-reported drug use in high risk populations: a meta-analytical review.

  1996cited by this paper
• Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard.

  1995cited by this paper
• Validation studies using an alloyed gold standard.

  1993cited by this paper
• Exposure measurement error: influence on exposure-disease. Relationships and methods of correction.

  1993cited by this paper
• Discrepancies between women's personal interview data and medical record documentation of illicit drug use, sexually transmitted diseases, and HIV infection.

  1992cited by this paper
• The effect of conditional dependence on the evaluation of diagnostic tests.

  1985cited by this paper
• Estimating the error rates of diagnostic tests.

  1980cited by this paper

• HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record Based Cohort Study.

  2025cites this paper
• Cohort profile update: the Johns Hopkins HIV clinical cohort, 1989–2023

  2024cites this paper
• The effect of antidepressant treatment on viral suppression among people with HIV diagnosed with depression in an urban clinic

  2024cites this paper
• Association of Alcohol Use with COVID-19 Infection and Hospitalization Among People Living with HIV in the United States, 2020

  2024cites this paper
• Long COVID in people living with HIV

  2023cites this paper
• Evaluating the agreement between different substance use recall periods in multiple HIV cohorts.

  2023cites this paper
• Hepatitis C treatment in people living with HIV: Potential to eliminate disease and disparity.

  2023cites this paper
• Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use

  2023cites this paper
• Joint effects of substance use disorders and recent substance use on HIV viral non-suppression among people engaged in HIV care in an urban clinic, 2014-2019.

  2023cites this paper
• Multilevel Resilience and HIV Virologic Suppression Among African American/Black Adults in the Southeastern United States

  2023cites this paper
• Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV

  2021cites this paper
• Neuroimaging the Neuropathogenesis of HIV

  2021cites this paper
• Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV.

  2021cites this paper
• Alcohol Use Disorder and Recent Alcohol Use and HIV Viral Non-Suppression Among People Engaged in HIV Care in an Urban Clinic, 2014–2018

  2021cites this paper
• A learning algorithm for predicting mental health symptoms and substance use.

  2020cites this paper
• Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association.

  2019cites this paper
• Recent Substance Use and Probability of Unsuppressed HIV Viral Load among Persons on Antiretroviral Therapy in Continuity Care.

  2019cites this paper
• AHA SCIENTIFIC STATEMENT Characteristics , Prevention , and Management of Cardiovascular Disease in People Living With HIV A Scientific Statement From the American Heart Association Circulation

  2019cites this paper
• Integration of care for HIV and opioid use disorder: a systematic review of interventions in clinical and community-based settings.

  2019cites this paper
• "No more falling through the cracks": A qualitative study to inform measurement of integration of care of HIV and opioid use disorder.

  2019cites this paper
• Integration of care for H IV and opioid use disorder

  2019influential citation
• Death after diagnosis of noncommunicable disease comorbid conditions, stratified by injection drug use

  2019cites this paper
• Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities

  2018cites this paper